# Alachua Government Services, Inc. clinical trials: 37 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials with Alachua Government Services, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Alachua Government Services, Inc.: 37 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/alachua-government-services-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 18, 2024 | NCT06507566 | Evaluating Technologies for Point-of-Care Blood Collections by Patients | Alachua Government Services, Inc. | Not applicable | Completed | Healthy | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06507566) |
| December 2, 2021 | NCT05142527 | Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19 | Alachua Government Services, Inc. | Phase 2/3 | Withdrawn | COVID-19 | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05142527) |
| January 12, 2021 | NCT04705844 | Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) | Alachua Government Services, Inc. | Phase 3 | Withdrawn | Mild to Moderate COVID-19 | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04705844) |
| October 19, 2020 | NCT04592549 | Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 | Alachua Government Services, Inc. | Phase 1 | Completed | SARS-CoV-2 | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04592549) |
| November 20, 2019 | NCT04171115 | Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects | Alachua Government Services, Inc. | Phase 1 | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04171115) |
| February 8, 2017 | NCT03046550 | Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults | Alachua Government Services, Inc. | Phase 1 | Completed | Healthy | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03046550) |
| July 30, 2013 | NCT01911754 | Japanese Pediatric H5N1 Vaccine Study | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01911754) |
| January 23, 2013 | NCT01774032 | H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01774032) |
| January 23, 2013 | NCT01773928 | Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza | 1,928 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01773928) |
| May 24, 2012 | NCT01604746 | Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 | Alachua Government Services, Inc. | Phase 3 | Completed | Prophylaxis of Ross River Virus Infection | 1,146 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01604746) |
| December 15, 2011 | NCT01492699 | Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Alachua Government Services, Inc. | Not applicable | Completed | Post Traumatic Stress Disorder | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01492699) |
| June 27, 2011 | NCT01382329 | H5N1 Vaccine Study in Japanese Adults | Alachua Government Services, Inc. | Phase 2/3 | Completed | H5N1 Influenza | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01382329) |
| March 22, 2011 | NCT01320696 | Reverse Genetic H9N2 Influenza Vaccine Study in Adults | Alachua Government Services, Inc. | Phase 1/2 | Completed | Influenza | 353 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01320696) |
| December 10, 2010 | NCT01258062 | Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults | Alachua Government Services, Inc. | Phase 1 | Completed | Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01258062) |
| November 17, 2010 | NCT01242670 | Ross River Virus (RRV) Vaccine Study | Alachua Government Services, Inc. | Phase 3 | Completed | Prophylaxis of Ross River Virus Infection | 1,968 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01242670) |
| July 7, 2010 | NCT01157702 | Yearly Strain Variation Study, 2010/2011 | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza, Seasonal Influenza | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01157702) |
| February 5, 2010 | NCT01063088 | Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza | 211 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01063088) |
| January 20, 2010 | NCT01052402 | Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents | Alachua Government Services, Inc. | Phase 1/2 | Completed | Influenza, Avian | 684 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01052402) |
| September 14, 2009 | NCT00976469 | A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents | Alachua Government Services, Inc. | Phase 1/2 | Completed | Influenza, Pandemic Influenza | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00976469) |
| August 14, 2009 | NCT00959465 | A/H1N1 Immunogenicity and Safety in Adults | Alachua Government Services, Inc. | Phase 1/2 | Completed | Influenza, Pandemic Influenza | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00959465) |
| July 31, 2009 | NCT00950456 | Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine | Alachua Government Services, Inc. | Observational | Completed | Influenza, Pandemic Influenza | 3,216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00950456) |
| July 22, 2009 | NCT00943657 | Yearly Strain Variation Study, 2009/2010 | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza, Seasonal Influenza | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00943657) |
| May 8, 2009 | NCT00895544 | Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults | Alachua Government Services, Inc. | Phase 1/2 | Completed | Influenza, Avian Influenza | 231 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00895544) |
| December 2, 2008 | NCT00800605 | Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection | Alachua Government Services, Inc. | Phase 3 | Completed | Influenza | 7,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00800605) |
| November 3, 2008 | NCT00783926 | Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant) | Alachua Government Services, Inc. | Phase 1 | Completed | Influenza, Pandemic Influenza | 422 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00783926) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 10 |
| Phase 2 | 1 |
| Phase 2/3 | 4 |
| Phase 3 | 14 |
| Not applicable | 2 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 35 |
| Withdrawn | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Influenza, Human | 24 |
| Influenza in Birds | 3 |
| Botulism | 1 |
| Ross River Virus Infection | 1 |
| COVID-19 | 1 |
| Stress Disorders, Post-Traumatic | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Computer wholesalers in the United States](https://specstream.ai/data/businesses/computer-wholesalers/united-states)
- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
- [Halal restaurants in the United States](https://specstream.ai/data/businesses/halal-restaurants/united-states)
- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Occupational medicine clinics in the United States](https://specstream.ai/data/businesses/occupational-medicine-clinics/united-states)
